Global biotechnology leader CSL announced positive top-line Phase 3 results for garadacimab (CSL312), the company's investigational first-in-class monoclonal antibody inhibiting Factor XIIa being developed...
Analysis Group, a global leader in health economics and outcomes research (HEOR) and regulatory epidemiology, announced that a study it coauthored helped support Blueprint...
Xenocor, a Utah-based medical device company, announced newly issued U.S. patent protection for the Saberscope system from the United States Patent and Trademark Office...
MicroGEM, a U.S.-based molecular biology company, announced that Medline, a manufacturer and distributor of medical supplies to healthcare providers across the continuum of care,...
Overjet, the dental industry leader in artificial intelligence solutions, announced it's expanding into Canada. The company received a Medical Device Establishment License (MDEL) from...
